<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RARE
Ultragenyx
$
()


  • Ultragenyx announces results from interim Phase 1/2 data of GTX-102

    4/15/2024 - 07:08am
  • Ultragenyx participates in a conference call hosted by Cantor Fitzgerald

    4/4/2024 - 10:25am
  • Ultragenyx participates in a conference call hosted by Cantor Fitzgerald

    4/4/2024 - 07:37am
  • JPMorgan ups Ultragenyx target, opens 'Positive Catalyst Watch' into data

    3/18/2024 - 07:15am
  • Ultragenyx price target raised by $1 at TD Cowen, here's why

    2/21/2024 - 07:37am
  • Ultragenyx price target raised by $1 at Wedbush, here's why

    2/16/2024 - 08:59am
  • Ultragenyx sees FY24 revenue $500M-$530M, consensus $504.31M

    2/15/2024 - 16:11pm
  • Ultragenyx reports Q4 EPS ($1.52), consensus ($1.62)

    2/15/2024 - 16:09pm
  • Ultragenyx announces data demonstrating treatment with UX111

    2/6/2024 - 08:10am
  • Ultragenyx pipeline undervalued ahead of 2024 catalysts, says Baird

    1/30/2024 - 06:33am
  • JPMorgan ups Ultragenyx target, adds to Analyst Focus List

    1/17/2024 - 07:41am
  • Ultragenyx price target lowered by $7 at Stifel, here's why

    1/15/2024 - 14:28pm
  • Mereo BioPharma provides update on pipeline progress, corporate developments

    1/8/2024 - 07:59am
  • Ultragenyx price target raised by $4 at Wedbush, here's why

    1/8/2024 - 07:46am
  • Ultragenyx reports preliminary 2023 revenue $430M-$435M, consensus $435.9M

    1/7/2024 - 13:52pm
dynamic_feed Breaking News